917396-20-4

Upstream product

• 917396-19-1 2-chloro-4,5-bis(4-chlorophenyl)-6-hydrazinylpyrimidine 
• 32315-10-9 bis(trichloromethyl) carbonate 

Relevant academic research and scientific papers

Triazolopyrimidine cannabinoid receptor 1 antagonists

The present application describes compounds according to both Formulas I and II, pharmaceutical compositions comprising at least one compound according to either Formula I or II and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formulas I and II both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formulas: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4 and R5 are described herein.